Communication

Publications

Return

Medical use of cannabis and cannabinoids: questions and answers for policymaking

Medical use of cannabis and cannabinoids: questions and answers for policymaking

EMCDDA. European Monitoring Centre for Drugs and Drug Addiction

What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue regulated in the EU? These and other questions are explored in this report which responds to growing interest in this topic as more European countries develop policies and practice in this area.  

Access

Upcoming activities

  • 2ª Reunión del Grupo de Trabajo 2 COPOLAD II en el ámbito de precursores

    Reducción de la Oferta de Drogas

    26/02/19 - 27/02/19

    Bruselas, Bélgica

  • 2ª Reunión del Grupo de Trabajo 1 COPOLAD II en el ámbito de precursores

    Reducción de la Oferta de Drogas

    28/02/19 - 01/03/19

    Bruselas, Bélgica

  • 3ª Reunión Anual de Observatorios Nacionales de Drogas COPOLAD II

    Observatorios Nacionales de Drogas

    25/03/19 - 29/03/19

    Praga, República Checa

See all activities